Provider availability varies. Call before scheduling. Some Nao providers can evaluate menopause symptoms and treatment questions, but prescribing and ongoing management depend on clinician scope, clinical findings, and follow-up needs. Gynecology or a menopause specialist may be recommended.
Perimenopause is the transition leading to menopause, often with changing periods and symptoms. Menopause is generally recognized after 12 months without a menstrual period when another cause does not explain it. Hot flashes, sleep disruption, vaginal discomfort and mood concerns deserve an individual assessment rather than one treatment for every symptom.
Changing ovarian hormone production contributes to symptoms. Systemic hormone therapy can treat vasomotor symptoms; low-dose vaginal estrogen treats local dryness and related discomfort. Lynkuet blocks NK1/NK3 receptors and Veozah blocks NK3 receptors to treat moderate to severe menopause-related hot flashes and night sweats. These pills are nonhormonal and have distinct monitoring and interaction requirements.
Review age, menstrual history, symptoms, pregnancy possibility and treatment goals. Hormone testing is not automatically necessary for a typical transition, but testing may help when the presentation is unusual or another illness is suspected. Whether systemic hormones are suitable depends on health history, including cancer, clots, stroke, cardiovascular and liver disease. A visit does not guarantee a prescription.
Choose a plan for the symptoms that most affect daily life. Discuss hormonal and nonhormonal options, sleep and vaginal care, contraception when still needed and bone health. If the uterus is present, systemic estrogen usually needs endometrial protection with a progestogen. Arrange product-specific testing and a review of benefit and adverse effects after starting.
Bring period dates, a hot-flash and sleep diary, medicines, prior hormone use and relevant records. Mention unexplained bleeding, cancer treatment, migraine, liver disease and pregnancy plans. Lynkuet requires pregnancy exclusion when relevant and baseline hepatic testing; Veozah requires baseline and scheduled follow-up liver tests. Tests for medication safety differ from tests to diagnose menopause.
Bleeding after menopause needs prompt evaluation rather than being assumed to be a normal hormone effect. Compounded bioidentical hormones are not established as safer than FDA-approved treatment. Lynkuet can cause sleepiness and daytime impairment and now has a seizure precaution; it is not a sleeping pill. Veozah has a boxed hepatotoxicity warning.
Review symptom frequency, sleep, vaginal comfort, functioning and adverse effects, then adjust treatment when needed. Benefit varies and a trial result does not guarantee a personal response. Continue required tests even if symptoms improve. Report jaundice, dark urine, marked fatigue or abdominal pain promptly when taking a medicine with liver precautions.
Confirm the clinic’s menopause evaluation, prescribing scope, examination and referral options. Separate the cost of the visit, labs and ongoing medicine. Bring prior treatment and symptom history for an insurance request; manufacturer support and samples do not guarantee covered refills. Before starting, know how repeat prescriptions, monitoring and urgent concerns will be handled.
Nao Medical Bartow Mall: 2063A Bartow Ave, Bronx, NY 10475. Call +1-917-310-3371 to confirm the specific service, clinician and appointment before travelling.
Contact the clinic to confirm this service, the clinician and appointment preparation. General clinic hours may differ from service appointment times.
The Bartow Mall clinic is at 2063A Bartow Ave, Bronx, NY 10475. Call the selected clinic to confirm today’s hours, the exact service and the appointment. An address does not prove onsite medication, testing or procedure availability.
A consultation starts with the clinical review and required records. Treatment or a procedure depends on suitability, the actual order, safety checks, staff, supplies and any authorization; booking does not guarantee a dose or procedure that day. Choose a plan for the symptoms that most affect daily life. Discuss hormonal and nonhormonal options, sleep and vaginal care, contraception when still needed and bone health. If the uterus is present, systemic estrogen usually needs endometrial protection with a progestogen. Arrange product-specific testing and a review of benefit and adverse effects after starting.
Bring period dates, a hot-flash and sleep diary, medicines, prior hormone use and relevant records. Mention unexplained bleeding, cancer treatment, migraine, liver disease and pregnancy plans. Lynkuet requires pregnancy exclusion when relevant and baseline hepatic testing; Veozah requires baseline and scheduled follow-up liver tests. Tests for medication safety differ from tests to diagnose menopause.
No. Lynkuet and Veozah are nonhormonal prescription treatments for moderate-to-severe menopause-related hot flashes and night sweats. Lynkuet blocks NK1/NK3 signaling, while Veozah blocks NK3. Neither is estrogen therapy, and their safety testing, interactions and contraindications differ. The clinician should choose according to your symptoms and health history.
Not every menopause visit requires the same blood tests. History and symptoms guide testing for other possible causes, while medicines can impose separate safety requirements. Veozah needs baseline and scheduled liver tests, and Lynkuet needs baseline and three-month liver review. Ask which tests apply to the treatment being considered.
Both are nonhormonal treatments for menopause-related vasomotor symptoms. Lynkuet blocks NK1/NK3, is taken at bedtime and needs baseline and three-month liver review plus sleepiness and seizure precautions. Veozah blocks NK3 and has a boxed liver warning with tests monthly for three months, then at six and nine months. They have different interactions and contraindications.
Lynkuet studies assessed hot-flash response over weeks, including at weeks 4 and 12. Improvement varies, and the clinician should agree on a review interval rather than promise a response by a fixed day. Track symptom frequency, sleep and adverse effects; its baseline and three-month liver checks and CNS precautions still apply.
Lynkuet can cause sleepiness and daytime impairment, but it is a hot-flash treatment, not a sleeping pill. Its label directs bedtime dosing. Avoid driving or hazardous activities until you know its effect and follow the prescriber’s advice. Review sedating medicines, alcohol, interactions and the current seizure precaution before use.
Coverage depends on the exact service, product, indication, provider and plan rules. Confirm the clinic’s menopause evaluation, prescribing scope, examination and referral options. Separate the cost of the visit, labs and ongoing medicine. Bring prior treatment and symptom history for an insurance request; manufacturer support and samples do not guarantee covered refills. Before starting, know how repeat prescriptions, monitoring and urgent concerns will be handled.
Focused evaluation for menopause-related vaginal or urinary symptoms and local treatment options.
Pap tests, pelvic concerns, birth-control visits, and broader women's health care.
Review Pap screening, cervical testing, and abnormal-result follow-up through the dedicated screening service.
Review fracture risk, outside DXA results, bone-health labs, and treatment or referral needs.
Arrange an evaluation to discuss suitable care, preparation and follow-up with a clinician.
Arrange an evaluation to discuss suitable care, preparation and follow-up with a clinician.
Content was updated August 4, 2026 using the sources cited above. Medical guidance, prescribing information, medication availability, and insurance rules can change. A licensed clinician must confirm current information and determine each patient's eligibility, testing, treatment, administration setting, and follow-up. Call 911 for a medical emergency. Contact Nao Medical with a question or correction.
(917) 310-3371